INS and Glucose intolerance: Furthermore, PLT3-treated mice exhibited significant improvements in glucose intolerance (Fig. 5h, i), insulin resistance (Fig. 5j, k), and hyperinsulinemia (5 l), suggesting that adipose-targeted delivery of T3 potently enhances insulin sensitivity.